EAN 2023 | Recent advancements in the development of seed amplification assays in PD

Matej Skorvanek, MD, PhD, Pavol Jozef Šafárik University, Košice, Slovakia, explores the shift in our understanding of Parkinson’s disease (PD) towards a biological classification of the condition. Several publications have recent emerged, aiming to present this new biological definition and classify PD into subtypes. A particularly promising recent advancement is the development of blood-based alpha-synuclein seed amplification assays, which could revolutionize the diagnostic process and lead to a more precise understanding of this complex condition. This interview took place at the European Academy of Neurology (EAN) 2023 Congress in Budapest, Hungary.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.